fluorescein has been researched along with folic acid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Imanishi, Y; Ito, Y; Kawazoe, N | 1 |
| Fan, J; Huennekens, FM | 1 |
| Low, PS; Lu, Y | 1 |
| Honscha, W; Kneuer, C | 1 |
| Baker, JR; Choi, Y; Islam, MT; Kotlyar, A; Thomas, T | 1 |
| Brennan, JD; Brook, MA; Covey, T; Hodgson, RJ; Kovarik, P | 1 |
| Dorton, R; Leamon, CP; Parker, N; Reddy, JA; Vetzel, M; Vlahov, I; Wang, Y; Westrick, E | 1 |
| Ding, H; Gu, Z; Li, L; Luo, K; Nie, Y; Zhang, Z | 1 |
| Baker, JR; Desai, A; Gordon, CL; Huang, B; Johnson, KB; Kukowska-Latallo, JF; Leroueil, PR; Tang, S; Zong, H | 1 |
| Kelderhouse, LE; Low, PS; Sturgis, JE; Vlashi, E | 1 |
| Amato, RJ; Carnahan, N; Ellis, PR; Low, PS; Lu, Y; Mohlere, V; Shetty, A | 1 |
| Aggarwal, C; Albelda, S; Barbosa, EM; DeJesus, E; Deshpande, C; Jiang, J; Judy, R; Low, PS; Nie, S; Okusanya, OT; Simone, CB; Singhal, S | 1 |
| Chen, K; Conti, PS; Fu, F; Huang, R; Liu, Z; Ma, W; Shi, X; Wang, J; Zhu, J; Zhu, Y | 1 |
| Chu, H; Leamon, CP; Lee, YG; Low, PS; Lu, Y; Putt, KS; Srinivasarao, M | 1 |
| Bhattacharyya, S; Horo, H; Kundu, LM; Mandal, B | 1 |
| Goel, L; Joshi, R; Ningthoujam, RS; Shelar, SB; Singh, BP; Srivastava, M | 1 |
1 trial(s) available for fluorescein and folic acid
| Article | Year |
|---|---|
A Phase I/Ib study of folate immune (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) with interferon-α and interleukin-2 in patients with renal cell carcinoma.
Topics: Adult; Aged; Cancer Vaccines; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Fluorescein; Folic Acid; Haptens; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome | 2014 |
15 other study(ies) available for fluorescein and folic acid
| Article | Year |
|---|---|
Patterned staining by fluorescein-labeled oligonucleotides obtained by in vitro selection.
Topics: Fluorescein; Fluoresceins; Folic Acid; Oligodeoxyribonucleotides; Staining and Labeling | 1996 |
Biotin derivatives of folate compounds: synthesis and utilization for visualization and affinity purification of folate transport proteins.
Topics: Animals; Bacterial Proteins; Biological Transport; Biotin; Carrier Proteins; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; Fluorescein; Fluoresceins; Folate Receptors, GPI-Anchored; Folic Acid; Leukemia L1210; Methotrexate; Microscopy; Molecular Structure; Receptors, Cell Surface; Sepharose; Tumor Cells, Cultured | 1997 |
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
Topics: Animals; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescein; Folic Acid; Haptens; Immunoglobulin G; Immunotherapy; Interferon-alpha; Interferon-gamma; Interleukin-2; Kinetics; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Models, Chemical; Neoplasms; Time Factors; Tumor Cells, Cultured | 2002 |
The H(+)-dependent reduced folate carrier 1 of humans and the sodium-dependent methotrexate carrier-1 of the rat are orthologs.
Topics: Amino Acid Sequence; Animals; Caco-2 Cells; Carrier Proteins; Cell Line, Tumor; Cricetinae; Fluorescein; Folic Acid; Humans; Hydrogen-Ion Concentration; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Mice; Minor Histocompatibility Antigens; Molecular Sequence Data; Rats; Reduced Folate Carrier Protein; Sequence Alignment; Sequence Homology, Amino Acid; Sodium; Spectrometry, Fluorescence | 2004 |
Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
Topics: Carrier Proteins; Cell Line, Tumor; DNA, Complementary; Drug Design; Evaluation Studies as Topic; Fluorescein; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Models, Biological; Molecular Structure; Molecular Weight; Oligonucleotides; Phosphates; Polyamines; Receptors, Cell Surface; Structure-Activity Relationship; Surface Properties | 2005 |
Capillary-scale frontal affinity chromatography/MALDI tandem mass spectrometry using protein-doped monolithic silica columns.
Topics: Automation; Binding Sites; Buffers; Chromatography, Affinity; Coumaric Acids; Fluorescein; Folic Acid; Image Interpretation, Computer-Assisted; Osmolar Concentration; Proteins; Pyrimethamine; Sensitivity and Specificity; Silicon Dioxide; Solvents; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrahydrofolate Dehydrogenase; Time Factors; Trimethoprim | 2005 |
Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Dose-Response Relationship, Drug; Drug Delivery Systems; Ethylenediamines; Female; Fluorescein; Folate Receptors, GPI-Anchored; Folic Acid; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Receptors, Cell Surface; Substrate Specificity; Xenograft Model Antitumor Assays | 2008 |
Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery.
Topics: Cations; DNA; Fluorescein; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; HeLa Cells; Humans; Models, Chemical; Nanoparticles; Polylysine; Polymers; Time Factors; Transfection | 2009 |
The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistry.
Topics: Azides; Click Chemistry; Copper; Dendrimers; Drug Delivery Systems; Fluorescein; Folic Acid; Humans; KB Cells; Methotrexate; Nanoparticles | 2012 |
Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors.
Topics: Cell Line, Tumor; Fluorescein; Folic Acid; Humans; Molecular Weight; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols | 2013 |
Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Contrast Media; Fluorescein; Folate Receptor 1; Folic Acid; Humans; Lung Neoplasms; Mediastinum; Middle Aged; Molecular Imaging; Monitoring, Intraoperative; Neoplasm Recurrence, Local | 2014 |
Topics: A549 Cells; Animals; Copper Radioisotopes; Dendrimers; Female; Fluorescein; Folate Receptors, GPI-Anchored; Folic Acid; Heterocyclic Compounds, 1-Ring; Humans; KB Cells; Mice, Nude; Neoplasms, Experimental; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2018 |
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters.
Topics: Animals; Cell Engineering; Cell Line, Tumor; Cytokines; Fluorescein; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Immune System Diseases; Immunotherapy, Adoptive; Lymphocyte Activation; Mice; Neoplasms; Receptors, Chimeric Antigen; Single-Chain Antibodies; Syndrome; T-Lymphocytes; Xenograft Model Antitumor Assays | 2019 |
Synthesis of functionalized silk-coated chitosan-gold nanoparticles and microparticles for target-directed delivery of antitumor agents.
Topics: Antineoplastic Agents; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fibroins; Fluorescein; Folic Acid; Gold; Green Chemistry Technology; HeLa Cells; Humans; Hydrogels; Metal Nanoparticles; Microscopy, Fluorescence; Microspheres; Molecular Weight; Particle Size; Silk; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles | 2021 |
Development of Core@Shell γ-Fe
Topics: Fluorescein; Fluorescein-5-isothiocyanate; Folic Acid; Humans; Hyperthermia; Hyperthermia, Induced; Nanoparticles; Silicon Dioxide | 2022 |